Skip to main content
Sale!

TB500 5mg

Original price was: $45.00.Current price is: $39.00.

TB-500 (Thymosin Beta-4) 5mg peptide for in vitro studies on tissue regeneration, inflammation, and cellular migration.

Out of stock

Category:

Description

TB-500 | 5mg

For In Vitro Research Use Only – Not for Human or Veterinary Use

 

Specifications:
  • Unit Size: 5mg
  • Form: Lyophilized powder
  • Purity: >99% (HPLC)
  • Molecular Weight: ~4963 Da
Intended Use:

This compound is strictly for in vitro laboratory research. It is not intended for human or animal use. Do not use in food, drugs, or diagnostic applications.

Legal Disclaimer:

This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. For research use only by qualified institutions.

Terms of Sale:

All sales from Onyx Research are final. Buyer affirms they are a licensed professional responsible for proper handling and compliance with all local regulations.

There are no reviews yet.

Be the first to review “TB500 5mg”

Your email address will not be published. Required fields are marked *

Related products

FDA Disclaimer

The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Products are not for human consumption.

Onyx Research is a chemical supplier. Onyx Research is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Onyx Research is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.

THE PRODUCTS WE OFFER ARE NOT INTENDED FOR HUMAN USE. THEY ARE INTENDED FOR IN-VITRO AND PRE-CLINICAL RESEARCH PURPOSES ONLY. THE CUSTOMER ACKNOWLEDGES THAT THERE ARE RISKS IN THE HANDLING, USE, AND DISTRIBUTION OF THESE PRODUCTS, AND CERTIFIES THAT IT HAS THE PROPER EQUIPMENT, FACILITIES, AND PERSONNEL FOR MANAGING THOSE RISKS; AND THE CUSTOMER KNOWINGLY ACCEPTS THESE RISKS.